ArticlePloS one2026
Applying normalized p-control charts for early detection of local COVID-19 outbreaks.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The COVID-19 pandemic underscored the urgent need for early detection of local outbreaks to enable better resource allocation and effective mitigation. Outbreak identification largely depended on local infection rates, which were highly variable and influenced by daily testing volumes. Effective pandemic management requires accurate, adaptive methods that reflect the dynamic and localized nature of these rates, ensuring timely and appropriate interventions. This study seeks to improve the early detection and localization of COVID-19 outbreaks through Statistical Process Control (SPC) and health data analytics. We propose an adaptive outbreak-detection framework that combines a normalized p-control chart with an Amplitude-based labeler (ABL). For each area and day, the monitored statistic is a standardized positivity-rate score, computed from the observed daily positivity rate, the number of tests performed that day, and an area-specific baseline positivity estimate derived from recent historical observations. This calibration is followed by Phase II sequential monitoring using fixed three-sigma limits on the normalized scale and Western Electric decision rules. The framework accommodates varying daily sample sizes, captures regional interconnectedness, and supports parameter tuning using a temporally ordered train/test design. Accounting for daily testing fluctuations and spatial variability, it enhances the accuracy of local outbreak detection. Compared with the benchmark outbreak-detection methods considered in this study, the proposed framework was evaluated on its ability to predict outbreak onset within the following three days, achieving overall accuracy of 0.81 and averaged precision and recall of 0.83 and 0.79, respectively. Performance was further evaluated using the Fβ-measure, enabling a flexible trade-off between precision and recall depending on the relative cost of errors. SPC-based methods like ours can significantly improve early outbreak detection and localization. In the post-vaccination era, when targeted responses are key to controlling localized spread while avoiding widespread restrictions, health data analytics offer a valuable tool for informed decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.